1.
Bioorg Med Chem Lett
; 24(13): 2802-6, 2014 Jul 01.
Artículo
en Inglés
| MEDLINE
| ID: mdl-24835199
RESUMEN
Human acrosin is an attractive target for the discovery of novel male contraceptives. Isoxazole derivative ISO-1, a small-molecule weak human acrosin inhibitor, was used as the starting point for lead optimization. After two rounds of structure-based inhibitor design, a highly potent inhibitor B6 (IC50=1.44 µM) was successfully identified, which showed good selectivity over trypsin and represents one of the most active human acrosin inhibitors up to date.